The FDA’s “seeming lack of participation” regarding the development of social media guidelines has frustrated many in the affected communities. But pharma specialist Mark Senak
says the recent influx of public comment submissions by pharma companies means the agency will soon face the challenge of “providing guidance that is broad enough to cover change.”
Pharma Companies Turn to FDA for Social Media Guidance
Posted on March 2nd, 2010 | More Digital & Social Media · Healthcare · Public Affairs
Related Posts
-
Leaked Documents Shed Light on More Than War in Afghanistan
Among obvious concerns, WikiLeaks’ release of more than 90,000 secret U.S. military documents relating to the war in Afghanistan will put the Obama administration’s “21st century statecraft” strategy to the test. The digital specialists from Public Affairs 2.0
take a look at what happens “when crisis communications takes on new meaning.”Posted on July 26th, 2010 | More Digital & Social Media · Public Affairs
-
What Women Really Want: New Insight About the Female Consumer
Marketers may be surprised to learn which sources of information women find essential to their shopping. The team from Word of Mouth
looks inside a Fleishman-Hillard study and discovers new insight into “what women are thinking.”Posted on July 22nd, 2010 | More Digital & Social Media · Moms · Research · Women · Word of Mouth
-
Pharma Meet Facebook, Facebook Meet Pharma
Pharma specialist Mark Senak
talks about the pharmaceutical industry’s slow adoption of Facebook and explains why medical product manufacturers should take advantage of this “extremely important referral source.”Posted on July 20th, 2010 | More Digital & Social Media · Healthcare · Public Affairs